Evogene Ltd. has released a new company presentation outlining its proprietary algorithms and technological capabilities in addressing real-world challenges. The presentation highlights key factors considered in Evogene's development process, including synthetic accessibility, chemical stability, molecular weight, metabolic stability, intellectual property and novelty, lipophilicity (LogP), hydrogen bond donors and acceptors, scaffold selection, and the use of machine learning models such as QSAR. These elements contribute to the company's approach to innovation in its field. You can access the full presentation through the link below.